[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-IMNM":3,"homepage-market-summary":31,"stock-news-IMNM":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"IMNM","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Immunome, Inc.","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.","177","Bothell, WA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},21.17,20.79,21.48,20.67,20.9,0.27,1.29,1215666.296172,18601,21.1311,30.06,12.41,1482007.88861449,49.6,1508,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,42,49,56,63,69],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":39,"is_up":40,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":40,"sparkline":75,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":40,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":14,"sparkline":90,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":40,"sparkline":97,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[99,104,109,114,119,124,129,134,139,144,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":40},"Technology","XLK",0.56,200.93,{"name":105,"etf":106,"change":107,"price":108,"is_up":40},"Financials","XLF",0.73,53.88,{"name":110,"etf":111,"change":112,"price":113,"is_up":40},"Healthcare","XLV",0.72,167.37,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",0.35,110.42,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.63,81.04,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.99,63.44,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.09,170.1,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",1.31,49.5,{"name":140,"etf":141,"change":142,"price":143,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":145,"etf":146,"change":117,"price":147,"is_up":40},"Utilities","XLU",39.97,{"name":149,"etf":150,"change":151,"price":152,"is_up":40},"Comm Services","XLC",1.17,111.61,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":40},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":160,"name":161,"price":162,"change":163,"is_up":40},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":165,"name":166,"price":167,"change":168,"is_up":40},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":170,"name":171,"price":172,"change":39,"is_up":40},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":174,"articles":175},9,[176,182,188,194,200,206,212,217,223],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Immunome (IMNM) Stock Looks Near Fair Value As Its 186% Run Continues - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxPTlltX09lSlhfZU1GdTlYeWhVemJBS0lESl9GLUN5YW5JYlRTMzNYNzFGMUhibkN1bkIwLXBhYjRCSnRWaERpMjNxSDA4U0lndV9pOUVUTUNjUFh2ckxLMDljdTRQUjB3NERyTkIzZGZxVEtnc2xuWENIeU9lSE80enRLNE1WTnprZTNLWVotTGFxVUxzTGlzSFFzNA?oc=5","Thu, 01 Oct 2026 09:11:34 GMT","Immunome (IMNM) Stock Looks Near Fair Value As Its 186% Run Continues Yahoo Finance","Yahoo Finance",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Immunome Stock Price Forecast. Should You Buy IMNM? - StockInvest.us","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiSEFVX3lxTFB1cnhwVHZ6QXFFT2F2WTVhMHdKamw1MTFnVkM5UHlBVF9nWXVCWXBYQWR6TGk4MlNNbzRRUTlGaDBwZVI4LWN0Zg?oc=5","Fri, 02 Oct 2026 22:22:37 GMT","Immunome Stock Price Forecast. Should You Buy IMNM? StockInvest.us","StockInvest.us",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Immunome (IMNM) Stock May Be A Bargain After IM 1340 Clearance - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 01 Oct 2026 23:27:20 GMT","Immunome (IMNM) Stock May Be A Bargain After IM 1340 Clearance Simply Wall Street","Simply Wall Street",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"FDA clears Immunome to test a cancer drug in people; a study is expected in the fourth quarter of 2026. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxPaTJaWC1GQ05vc0JGTHc2bG40S3hyRy0xTU9SdzJGc2J5RFJyUS1BV3ZYbTRlcWtScWpmQ1JNRHBGLV9jTkpHaEUtYlFTNlNzdEZmdXhCc2d0WkYwNjh5cm1kMk1ObS1aOVFoQ0toakRBYzlyX0U1U3h4MHZMSlVFcXNQQ0M0cEx4UmhKcU5MWGxMaDVDZmZoTFB5YjhxTFA2OU9jMXgxX1VHb2NZN2xnVW1vd0tPT3RONzhGZQ?oc=5","Wed, 30 Sep 2026 11:45:00 GMT","FDA clears Immunome to test a cancer drug in people; a study is expected in the fourth quarter of 2026. Stock Titan","Stock Titan",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"Price-Driven Insight from (IMNM) for Rule-Based Strategy - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizwFBVV95cUxONVVqSXd0YW5tZU9kRnozdjlpT01pSnY5RHM3Sk1LNXY3Vml3VEt6NkpPRnYxMU5wajRBVENRUE9fbjJBajJqN1pxeHlNY0dPT05YYUtwaFlxbnU5TE83TGU1REtmUnEzSjV5SXZ4aURXdFBJYUJhRHRibEc4WmJ6azd2dlNreVZDd3NnQ3R2X1cyckhpNjRjXzBUdWdxM1VXWGlxbGlEZHN3Q21vb2tlLXZUUmZRV2xldDFRaVV5cGJZLS0wNnNpdDY2R1B3aTg?oc=5","Fri, 02 Oct 2026 08:04:01 GMT","Price-Driven Insight from (IMNM) for Rule-Based Strategy Stock Traders Daily","Stock Traders Daily",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"Immunome (IMNM) Gains FDA IND Clearance for IM-1340 Targeting Ad - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxQMU03V1M5QUJ6akRlbV9MdmhuWGg1clItdE9LUTcyTHRUUWdQTjU1RnNlZXdXd09DN2ozTXV0dV91bC1zZ2FsLWl2eTVmR1ZWbHVYekszMjRvNHNic0NManl5Rzc2UjdkSkZYSU13TUZ0X2hfQmYwYmhiZEl6OHFaYklRNUxhSC04dHoxTG9aRXF0N3lVZ2xHWC02cks4MjNQLTdhS1RNaVQ0YmFsZFNzNjdiSmtnanpIODg0?oc=5","Wed, 30 Sep 2026 12:43:14 GMT","Immunome (IMNM) Gains FDA IND Clearance for IM-1340 Targeting Ad GuruFocus","GuruFocus",{"title":213,"link":214,"pubDate":215,"description":216,"source":211},"IMNM Initiated Coverage by Stifel -- Rated Hold with PT at $24.0 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxPb3ZXY2g4U0NMOUhfcHJjbDlWbGRqSTdFVE13YXR0dHZPdEhIV1J5T1lHUk56ZkdfSXJXSUhFMjZDX0VUS09mN3BUSzdzdkxKWmhlVmstckI1dEJ5UFhUVjFlSHNxRDNXNlo4TFVyS05zajg2cER5RmJWVG0yVHRkaDhIanI2LVVKWE15eURQX3NnU0NGQlFHdTZBak9YLUdv?oc=5","Thu, 01 Oct 2026 11:48:12 GMT","IMNM Initiated Coverage by Stifel -- Rated Hold with PT at $24.0 GuruFocus",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"Immunome stock gets FDA clearance for fifth clinical program - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxQbmRjRVhvT0lXYW8wVEVnSTNtZG1sOEZQUXoxSG5VLXZBbGx0aHNzZHhuQnRIUTNPaGUyeF84VlZteU5rSWxkdXBRUVRRbDdiSHpodVdSQzlxemotX0dFNzU3X0luMlZ0XzZ4VVhQeThnTFF0emZWbXliS3UtLTRkekVOY2FXdUZfblJ6aVNYbWJPUlNGbXhVajR0bnRoeWlyVC1CR3dPMmpRZ3REU0lIcm82dmFsLTdrNkZWdUtGakc?oc=5","Mon, 05 Oct 2026 08:43:43 GMT","Immunome stock gets FDA clearance for fifth clinical program AD HOC NEWS","AD HOC NEWS",{"title":224,"link":225,"pubDate":226,"description":227,"source":228},"Immunome Restructures BMS Deal, Gains Key Patent Rights - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxOQTBtTXMzQ2U5M0tVR3NmeTR3WjRNV3drUklTd2R0VEZGVVFSLW8wUDhQTzhrNHFVdktybjNLU0VMWmpiODRFbEprNUpxTW9vUUlWUHZQSWhOYzBaVmM0cndlZ1dIeldnM1JPdzRmT0RZT052MWhHbjhjNWpZMm5PU2lFY0tUaG9Mb2tyMFJOb3czUnBQUy1KbWRkV09lZHBURHpOQzVTYUt6dw?oc=5","Mon, 05 Oct 2026 13:12:02 GMT","Immunome Restructures BMS Deal, Gains Key Patent Rights TipRanks","TipRanks"]